177 related articles for article (PubMed ID: 34819103)
21. The Significance of Staging Laparoscopy in Detection of Radiologically Occult Peritoneal Carcinomatosis in Gastric Cancer With Gastric Outlet Obstruction: Consideration of The Optimal Treatment Approach.
Komatsu M; Kinoshita T; Akimoto E; Yoshida M; Terajima D; Nagata H; Habu T; Okayama T; Takabe Y; Harada J; Yamaguchi M; Yura M
Anticancer Res; 2022 Nov; 42(11):5571-5578. PubMed ID: 36288848
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.
Glehen O; Schreiber V; Cotte E; Sayag-Beaujard AC; Osinsky D; Freyer G; François Y; Vignal J; Gilly FN
Arch Surg; 2004 Jan; 139(1):20-6. PubMed ID: 14718269
[TBL] [Abstract][Full Text] [Related]
23. Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.
Geng X; Liu H; Lin T; Hu Y; Chen H; Zhao L; Mou T; Qi X; Yu J; Li G
Cancer Med; 2016 Oct; 5(10):2781-2791. PubMed ID: 27650694
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
[TBL] [Abstract][Full Text] [Related]
25. Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.
Magge D; Zenati M; Mavanur A; Winer J; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2014 May; 21(5):1448-55. PubMed ID: 24197761
[TBL] [Abstract][Full Text] [Related]
26. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'.
Marano L; Marrelli D; Sammartino P; Biacchi D; Graziosi L; Marino E; Coccolini F; Fugazzola P; Valle M; Federici O; Baratti D; Deraco M; Di Giorgio A; Macrì A; Pasqual EM; Framarini M; Vaira M; Roviello F;
Ann Surg Oncol; 2021 Dec; 28(13):9060-9070. PubMed ID: 34057569
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis.
Hioki M; Gotohda N; Konishi M; Nakagohri T; Takahashi S; Kinoshita T
World J Surg; 2010 Mar; 34(3):555-62. PubMed ID: 20082194
[TBL] [Abstract][Full Text] [Related]
28. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O;
Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
30. Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis.
Gretschel S; Siegel R; Estévez-Schwarz L; Hünerbein M; Schneider U; Schlag PM
Br J Surg; 2006 Dec; 93(12):1530-5. PubMed ID: 17051604
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.
Di Giorgio A; Gerardi C; Abatini C; Melotti G; Bonavina L; Torri V; Santullo F; Garattini S; De Luca M; Rulli E; Rulli E; Pacelli F;
Trials; 2022 Dec; 23(1):969. PubMed ID: 36457115
[TBL] [Abstract][Full Text] [Related]
32. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery.
Fujimoto S; Takahashi M; Mutou T; Kobayashi K; Toyosawa T; Isawa E; Sumida M; Ohkubo H
Cancer; 1997 Mar; 79(5):884-91. PubMed ID: 9041149
[TBL] [Abstract][Full Text] [Related]
33. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
Ripley RT; Davis JL; Kemp CD; Steinberg SM; Toomey MA; Avital I
Trials; 2010 May; 11():62. PubMed ID: 20500867
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.
Bonnot PE; Piessen G; Kepenekian V; Decullier E; Pocard M; Meunier B; Bereder JM; Abboud K; Marchal F; Quenet F; Goere D; Msika S; Arvieux C; Pirro N; Wernert R; Rat P; Gagnière J; Lefevre JH; Courvoisier T; Kianmanesh R; Vaudoyer D; Rivoire M; Meeus P; Passot G; Glehen O;
J Clin Oncol; 2019 Aug; 37(23):2028-2040. PubMed ID: 31084544
[TBL] [Abstract][Full Text] [Related]
35. Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab.
Goéré D; Gras-Chaput N; Aupérin A; Flament C; Mariette C; Glehen O; Zitvogel L; Elias D
BMC Cancer; 2014 Mar; 14():148. PubMed ID: 24589307
[TBL] [Abstract][Full Text] [Related]
36. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC).
Garland-Kledzik M; Uppal A; Naeini YB; Stern S; Erali R; Scholer AJ; Khader AM; Santamaria-Barria JA; Cummins-Perry K; Zhou Y; Votanopoulos KI; Shen P; Levine EA; Bilchik AJ
J Gastrointest Surg; 2021 Jan; 25(1):233-240. PubMed ID: 33269456
[TBL] [Abstract][Full Text] [Related]
38. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
[No Abstract] [Full Text] [Related]
39. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.
Boerner T; Graichen A; Jeiter T; Zemann F; Renner P; März L; Soeder Y; Schlitt HJ; Piso P; Dahlke MH
Ann Surg Oncol; 2016 Nov; 23(12):3972-3977. PubMed ID: 27313067
[TBL] [Abstract][Full Text] [Related]
40. Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases.
Steinhoff H; Acs M; Blaj S; Dank M; Herold M; Herold Z; Herzberg J; Sanchez-Velazquez P; Strate T; Szasz AM; Piso P
World J Gastroenterol; 2023 May; 29(18):2850-2863. PubMed ID: 37274066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
